Covered recipient · General Payments record
DAVID SETH SHARE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$607.53
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.85 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $66.28 | 3 |
| ABBVIE INC. | $51.40 | 2 |
| Amgen Inc. | $49.34 | 3 |
| PFIZER INC. | $41.09 | 2 |
| Inspire Medical Systems, Inc. | $37.81 | 2 |
| Seqirus USA Inc | $32.86 | 1 |
| EISAI INC. | $31.12 | 1 |
| Otsuka America Pharmaceutical, Inc. | $27.02 | 1 |
| GlaxoSmithKline, LLC. | $20.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.25 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073802 | CMS |
| ABBVIE INC. | $28.15 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073804 | CMS |
| Amgen Inc. | $15.83 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117380568 | CMS |
| Amgen Inc. | $17.46 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111704644 | CMS |
| Amgen Inc. | $16.05 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111704646 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.24 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118138254 | CMS |
| Eisai Inc. | $31.12 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110740661 | CMS |
| GlaxoSmithKline, LLC. | $20.69 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116442967 | CMS |
| Inspire Medical Systems, Inc. | $16.56 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148109623 | CMS |
| Inspire Medical Systems, Inc. | $21.25 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148109627 | CMS |
| Novo Nordisk Inc | $20.03 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097698489 | CMS |
| Novo Nordisk Inc | $19.32 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096783741 | CMS |
| Novo Nordisk Inc | $26.93 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097116018 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.02 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118980612 | CMS |
| PFIZER INC. | $25.38 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131240471 | CMS |
| PFIZER INC. | $15.71 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131486946 | CMS |
| Seqirus USA Inc | $32.86 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125635393 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.